GIA GABRIELLE RANADA: Open Payments
NPI 1700567948 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$244 in 11 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $208 · 2025 $244
Food & beverage: $244
| Company | Payments | Amount |
|---|---|---|
| Merz Pharmaceuticals, LLC | 2 | $73 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $66 |
| ABBVIE INC. | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| PFIZER INC. | 1 | $16 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $15 |
Products named: Xeomin, RELISTOR, XTAMPZA, QULIPTA, NURTEC ODT, UBRELVY, JOURNAVX.
Industry payments across MA — which companies pay providers there.
